Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 48 - You Need To See This

The growing fad of ‘microdosing’ mushrooms is leading to an uptick in poison control center calls and emergency room visits

Imagine you purchase a bag of gummies labeled nootropic – a term used to describe substances that claim to enhance mental ability and function, or “smart drugs.” However, within hours of consuming them, your heart starts racing, you’re nauseated and vomiting. Then you begin convulsing and have a seizure, resulting…

The Conversation

Whoop refuses to back down after FDA calls blood pressure feature a medical device

The battle over blood pressure tracking could reshape what wearables can legally do (in the US)

FDA warns lead could be leaching into food from this cookware

Lead is toxic to people of any age or health status and higher exposure levels can lead to neurological changes

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Faith-based activist groups celebrate after Costco bails on selling abortion pill

‘They have nothing to gain and much to lose by becoming abortion dispensaries,’ Alliance Defending Freedom Legal Counsel Michael Ross said

The Independent UK

What's Going On With Tonix Pharmaceuticals (TNXP) Stock?

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have rallied 30% over the past five sessions, though are marginally lower Thursday afternoon, as investors anticipate a key catalyst for the company.

Benzinga

7 Products Pulled for Undisclosed Ingredients

When a food company recalls a product, it is often because of a serious and potentially life-threatening mistake: the presence of an undisclosed ingredient. This usually happens when a major allergen, like nuts or dairy, is accidentally introduced into a product that is not supposed to contain it. For people…

Grocery Coupon Guide

Whoop stands firm against FDA pressure over Blood Pressure insights tool

Whoop and the FDA clashed in recent issues over the former's BPI tool on its MG fitness band.

Android Central

Read news from The Economist, FT, and more,
with one subscription

8 Snack Labels That Mislead About Health Benefits

Walk down any grocery store snack aisle, and you’ll find products proudly displaying labels like “natural,” “low-fat,” or “made with real fruit.” These claims sound reassuring, but they don’t always tell the full story. In reality, some so-called healthy snacks are packed with sugar, sodium, or artificial additives that can…

Grocery Coupon Guide

Laura Loomer sets her sights on her next target to get the boot from the Trump administration

‘I’m not naive enough to think that the president is going to get rid of RFK, but I will say that … there are concerns about some of the staffing decisions over at HHS,’ Laura Loomer said this week.

The Independent UK

COVID-19 vaccines for kids are mired in uncertainty amid conflicting federal guidance

It’s August, and parents and caregivers are frantically preparing their kids for a new school year by buying supplies, filling out forms and meeting teachers. This year, many parents also face a question that’s more complicated than usual: Should my child get an updated COVID-19 vaccine, and will I even…

The Conversation

Cognition Therapeutics Surges 30% Pre-Market After FDA Backs Phase 3 Trial Design For Alzheimer's Drug

Cognition Therapeutics Inc. (NASDAQ:CGTX) shares jumped 30% to $1.43 in pre-market trading on Wednesday after the company announced FDA confirmation of its Phase 3 trial design for Alzheimer’s drug Zervimesine (CT1812).

Benzinga

Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside

Per two Wall Street analysts, one of 2025's biggest losers could be set up for a stunning recovery. They see over 175% upside in Sarepta Therapeutics.

MarketBeat

Why Is Liquidia Stock Trading Higher On Tuesday?

Liquidia Corporation (NASDAQ:LQDA) reported on Tuesday a second-quarter loss of 49 cents, missing the consensus of a loss of 43 cents.

Benzinga

FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease

The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years and older.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

A group of former U.S. Centers for Disease Control and Prevention (CDC) employees are blaming HHS Secretary Robert F. Kennedy Jr. for vilifying the agency’s workforce through “his continuous lies about science and vaccine safety, which have fueled a climate of hostility and mistrust."

Benzinga

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously referred to as AMP-002.

Benzinga

Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now

Hims Hers Health Inc. (NYSE:HIMS) has been one of 2025’s hottest telehealth stocks, nearly doubling in value year to date, but a deepening clash with Novo Nordisk A/S (NYSE:NVO) over compounded weight-loss drugs, and shifting FDA rules, has turned momentum into headwinds, sending shares sliding 10% in the past three…

Grocery Coupon Guide

7 Times Pet Food Was Recalled Without National Coverage

When a major pet food recall happens, it often makes national news, sending worried pet owners rushing to check their pantries. However, many smaller recalls issued by the U.S. Food and Drug Administration (FDA) never make the headlines. These quiet recalls can involve products contaminated with dangerous bacteria like Salmonella…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are trading sharply higher Tuesday morning following the release of the company’s second-quarter financial results and operational update.

Benzinga

Altimmune Q2 FY2025 Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.

The Independent UK

Sugar cookies sold at Target in 20 states recalled over fears of wood chip contamination

More than 800 cases of the sugar cookies were recently recalled

Grocery Coupon Guide

5 Health Food Trends That Quietly Lost FDA Backing

For years, certain “health food” products have been promoted as miracle solutions for weight loss, better digestion, and overall wellness. Shoppers stocked their pantries with these items, trusting bold packaging claims and viral endorsements. But behind the scenes, the FDA has quietly shifted its stance on some of these trends—removing…

Benzinga

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply

View Preview

The Independent UK

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top vaccine regulator

Barchart

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

Alnylam Pharmaceuticals (ALNY) shows strong price momentum, hitting new all-time highs on Aug. 11. ALNY has a 100% technical “Buy” opinion via Barchart. The company boasts a robust pipeline, recent FDA approvals, and dramatic projected revenue and earnings growth for 2025. Analyst sentiment is mostly bullish with high price targets....

1 … 47 48 49 50

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.